TOPOTECAN , DOSTARLIMAB , BEVACIZUMAB , PACLITAXEL , NIRAPARIB , DOXORUBICIN , GEMCITABINE
MITO 33
Phase 3 small_molecule active
Quick answer
TOPOTECAN , DOSTARLIMAB , BEVACIZUMAB , PACLITAXEL , NIRAPARIB , DOXORUBICIN , GEMCITABINE for Recurrent ovarian, fallopian tube or primary peritoneal cancer is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Recurrent ovarian, fallopian tube or primary peritoneal cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active